Form D · Venture Capital Fund

AVSF - Arda Therapeutics 2024, LLC

Boston, MA · CIK 0002030195

Offering snapshot reported Aug 5, 2024 · SEC filing

Reported sold
$575K
Offering amount: $575K
Investors reported
33
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Jul 22, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 5, 2024Initial$575,000No comparison33SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-520590

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NoneNone

Source: Form D, filed Aug 5, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

AVSF - ARDA THERAPEUTICS 2024, LLC

Investment adviser: ALUMNI VENTURES, LLC

Gross asset value
$495K
Beneficial owners
36
ADV minimum commitment
$10K

Reported in Form ADV on Mar 24, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
No
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No
Filing source

Form ADV 2067584 · Mar 24, 2026 · Schedule D 7.B.(1), fund 805-2552692915

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael St Collins Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
70 Federal Street 6th Floor
Boston, MA, 02110